Ignite Creation Date:
2025-12-25 @ 5:04 AM
Ignite Modification Date:
2026-03-08 @ 4:48 AM
Study NCT ID:
NCT02910518
Status:
COMPLETED
Last Update Posted:
2022-04-25
First Post:
2016-09-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Demonstrate Bioequivalence Between Insulin Glulisine U300 and Insulin Glulisine U100 After a Single Subcutaneous Dose Using the Euglycemic Clamp Technique, in Patients With Type 1 Diabetes Mellitus
Sponsor:
Sanofi
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-02-17
Start Date Type:
ACTUAL
Primary Completion Date:
2017-05-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-05-03
Completion Date Type:
ACTUAL
First Submit Date:
2016-09-20
First Submit QC Date:
None
Study First Post Date:
2016-09-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-04-21
Last Update Post Date:
2022-04-25
Last Update Post Date Type:
ACTUAL